EP1451308A4 - Therapeutische verwendung von aziridinoverbindungen - Google Patents
Therapeutische verwendung von aziridinoverbindungenInfo
- Publication number
- EP1451308A4 EP1451308A4 EP02806003A EP02806003A EP1451308A4 EP 1451308 A4 EP1451308 A4 EP 1451308A4 EP 02806003 A EP02806003 A EP 02806003A EP 02806003 A EP02806003 A EP 02806003A EP 1451308 A4 EP1451308 A4 EP 1451308A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- therapeutic use
- aziridino compounds
- aziridino
- compounds
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/396—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having three-membered rings, e.g. aziridine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2001/049956 WO2002055095A2 (en) | 2000-11-06 | 2001-11-06 | Use of aziridino-compounds in the treatment of immune dysfunctions |
WOPCT/US01/49956 | 2001-11-06 | ||
US36564802P | 2002-03-18 | 2002-03-18 | |
US365648P | 2002-03-18 | ||
US37918802P | 2002-05-09 | 2002-05-09 | |
US379188P | 2002-05-09 | ||
PCT/US2002/035501 WO2003066806A2 (en) | 2001-11-06 | 2002-11-05 | Therapeutic use of aziridino compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1451308A2 EP1451308A2 (de) | 2004-09-01 |
EP1451308A4 true EP1451308A4 (de) | 2004-11-17 |
Family
ID=27738963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02806003A Withdrawn EP1451308A4 (de) | 2001-11-06 | 2002-11-05 | Therapeutische verwendung von aziridinoverbindungen |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1451308A4 (de) |
JP (1) | JP2005517023A (de) |
AU (1) | AU2002366446A1 (de) |
CA (1) | CA2466251A1 (de) |
WO (1) | WO2003066806A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040053208A1 (en) * | 1995-08-29 | 2004-03-18 | V. I. TECHNOLOGIES, Inc. | Methods to selectively inactivate parasites in biological compositions |
US9040507B2 (en) | 2008-06-02 | 2015-05-26 | Novelmed Therapeutics, Inc. | Method for treating inflammatory conditions |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0419890A2 (de) * | 1989-09-29 | 1991-04-03 | American Cyanamid Company | Stabile Arzneiformulierungen für antineoplastische Verbindungen mit mehr als einer Ethylenimingruppe sowie Verfahren |
WO1997007674A1 (en) * | 1995-08-29 | 1997-03-06 | Pentose Pharmaceuticals, Inc. | Methods and compositions for the selective modification of nucleic acids |
WO2002055095A2 (en) * | 2000-11-06 | 2002-07-18 | Vi Technologies Inc | Use of aziridino-compounds in the treatment of immune dysfunctions |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6136586A (en) * | 1995-08-29 | 2000-10-24 | Vi Technologies, Inc. | Methods for the selective modification of viral nucleic acids |
US6093564A (en) * | 1997-10-03 | 2000-07-25 | V.I. Technologies, Inc. | Methods and compositions for the selective modification of nucleic acids |
-
2002
- 2002-11-05 EP EP02806003A patent/EP1451308A4/de not_active Withdrawn
- 2002-11-05 JP JP2003566157A patent/JP2005517023A/ja active Pending
- 2002-11-05 CA CA002466251A patent/CA2466251A1/en not_active Abandoned
- 2002-11-05 WO PCT/US2002/035501 patent/WO2003066806A2/en not_active Application Discontinuation
- 2002-11-05 AU AU2002366446A patent/AU2002366446A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0419890A2 (de) * | 1989-09-29 | 1991-04-03 | American Cyanamid Company | Stabile Arzneiformulierungen für antineoplastische Verbindungen mit mehr als einer Ethylenimingruppe sowie Verfahren |
WO1997007674A1 (en) * | 1995-08-29 | 1997-03-06 | Pentose Pharmaceuticals, Inc. | Methods and compositions for the selective modification of nucleic acids |
WO2002055095A2 (en) * | 2000-11-06 | 2002-07-18 | Vi Technologies Inc | Use of aziridino-compounds in the treatment of immune dysfunctions |
Non-Patent Citations (5)
Title |
---|
CHAPMAN JOHN: "Progress in improving the pathogen safety of red cell concentrates.", VOX SANGUINIS, vol. 78, no. Suppl. 2, July 2000 (2000-07-01), pages 203 - 204, XP008004989, ISSN: 0042-9007 * |
FAST-L: "Treatment of human leukocytes with inactine-TM results in loss of function and induction of apoptosis", BLOOD, vol. 96, no. 11, 16 November 2000 (2000-11-16), pages 61A, XP001073993 * |
KASERMANN FABIAN ET AL: "Virus inactivation and protein modifications by ethyleneimines", ANTIVIRAL RESEARCH, vol. 52, no. 1, October 2001 (2001-10-01), pages 33 - 41, XP002296019, ISSN: 0166-3542 * |
PURMAL ANDREI ET AL: "Process for the preparation of pathogen-inactivated RBC concentrates by using PEN110 chemistry: Preclinical studies", TRANSFUSION (BETHESDA), vol. 42, no. 2, February 2002 (2002-02-01), pages 139 - 145, XP002296020, ISSN: 0041-1132 * |
RICHTER H I ET AL: "[Extracorporeal photopheresis in therapy-refractory disseminated discoid lupus erythematosus]", DER HAUTARZT;ZEITSCHRIFT FUR DERMATOLOGIE, VENEROLOGIE, UND VERWANDTE GEBIETE. GERMANY JUN 1998, vol. 49, no. 6, June 1998 (1998-06-01), pages 487 - 491, XP002203620, ISSN: 0017-8470 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003066806A3 (en) | 2003-12-24 |
WO2003066806A2 (en) | 2003-08-14 |
CA2466251A1 (en) | 2003-08-14 |
AU2002366446A1 (en) | 2003-09-02 |
EP1451308A2 (de) | 2004-09-01 |
JP2005517023A (ja) | 2005-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1416884A4 (de) | Abgabe von mitteln mit therapeutischen eigenschaften | |
IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
IL156595A0 (en) | Therapeutic heterocyclic compounds | |
GB0013378D0 (en) | Use of therapeutic benzamide derivatives | |
GB0305150D0 (en) | Use of therapeutic compounds | |
GB0108930D0 (en) | Therapeutic agents | |
HUP0500734A3 (en) | Use of 2-alkoxyphenyl-substituted imidazotriazinones | |
GB0119025D0 (en) | Compounds and their therapeutic use | |
HK1070561A1 (en) | Use of specific dose of fandaparinux sodium for the treatment of acs | |
EP1451308A4 (de) | Therapeutische verwendung von aziridinoverbindungen | |
GB2376943B (en) | Compounds and their therapeutic use | |
GB0108982D0 (en) | Therapeutic agents | |
GB0112237D0 (en) | Compounds and their therapeutic use | |
GB0128122D0 (en) | Therapeutic use | |
GB0123991D0 (en) | New therapeutic use | |
EP1377289A4 (de) | Heterozyklische verbindungen für therapeutische zwecke | |
GB0024517D0 (en) | Use of medicaments | |
GB0108973D0 (en) | Therapeutic agents | |
GB0130736D0 (en) | Compounds and their therapeutic use | |
GB0128512D0 (en) | Compounds and their therapeutic use | |
GB0105097D0 (en) | Treatment of technetium | |
GB0104615D0 (en) | Treatment of technetium | |
GB0118627D0 (en) | Use of compounds in therapy | |
GB0128090D0 (en) | Therapeutic use | |
GB0128128D0 (en) | Therapeutic use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040524 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61P 35/00 B Ipc: 7A 61P 37/00 B Ipc: 7A 61K 31/395 B Ipc: 7A 61K 35/14 A |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20041004 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20050601 |